ArticleActa oncologica (Stockholm, Sweden)2025

Predicting neoadjuvant chemotherapy treatment response in hormone- receptor-positive/HER2-negative breast cancer - results from the Swedish SCAN-B population-based cohort.

Niklas Loman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.